ANTARES PHARMA, INC. 4
4 · ANTARES PHARMA, INC. · Filed Jun 9, 2017
Insider Transaction Report
Form 4
SAMSON MARVIN
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-07+80,318→ 80,318 totalExercise: $2.66Exp: 2027-06-07→ Common Stock (80,318 underlying)
Footnotes (2)
- [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F2]The options vest in equal quarterly installments over one year from grant date.